COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Food and Drug Administration May 27 authorized the emergency use of the Stryker Sustainability Solutions VHP N95 Respirator Decontamination System during the COVID-19 pandemic.
A new Centers for Disease Control and Prevention study released shows community transmission of COVID-19 in the U.S. was occurring in February of this year.
FDA issued a reminder to health care facilities’ reprocessing staffs to follow the agency-outlined decontamination cycle when using the ASP STERRAD Sterilization System to decontaminate N95 or N95-equivalent respirators for reuse via vaporized hydrogen peroxide.
The FDA authorized the emergency use of certain personal protective equipment to help address insufficient supply due to the COVID-19 pandemic.
The Centers for Medicare & Medicaid Services released a fact sheet for state and local governments seeking Medicare, Medicaid or Children’s Health Insurance Program payment for inpatient and outpatient care provided at hospital alternative care sites during the COVID-19 emergency.
The Centers for Disease Control and Prevention issued interim guidelines for serologic methods used for monitoring and responding to the COVID-19 pandemic.
CMS issued a rule finalizing certain telehealth and network adequacy proposals for Medicare Advantage and Part D prescription drug plans for contract years 2021 and 2022, as well as certain provisions of the Bipartisan Budget Act of 2018 and 21st Century Cures Act, among other changes. The agency…
The Food and Drug Administration approved two abbreviated new drug applications expected to alleviate shortages and help during the COVID-19 emergency.
The FDA updated two guidances for the temporary compounding of certain drugs used to treat COVID-19 patients.
The FDA posted a list of COVID-19 antibody tests that will no longer be marketed because they have not been authorized for emergency use under its revised policy, or the manufacturer withdrew them from the list of tests under review for emergency use.